Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
186.16
+6.98 (3.90%)
At close: Jul 17, 2026, 4:00 PM EDT
184.37
-1.79 (-0.96%)
After-hours: Jul 17, 2026, 7:14 PM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $39.58 billion as of July 17, 2026. Its market cap has increased by 453.32% in one year.
Market Cap
39.58B
Enterprise Value
37.70B
1-Year Change
453.32%
Ranking
Category
Stock Price
$186.16
ChartMarket Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $39.58B, an increase of 2,306.66%. That is a compound annual growth rate of 64.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 39.58B | 157.03% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 67.72B |
| argenx SE | 54.49B |
| Alnylam Pharmaceuticals | 37.50B |
| BeOne Medicines AG | 34.77B |
| Royalty Pharma | 32.32B |
| Moderna | 26.63B |
| Roivant Sciences | 25.10B |
| Insmed | 23.70B |